Scarica l'app Stockscreener
32.25
4.13%
-1.39
Dopo l'orario di chiusura:
32.22
-0.03
-0.09%
Precedente Chiudi:
$33.64
Aprire:
$33.26
Volume 24 ore:
534.28K
Relative Volume:
0.70
Capitalizzazione di mercato:
$1.47B
Reddito:
$1.23B
Utile/perdita netta:
$20.43M
Rapporto P/E:
73.11
EPS:
0.4411
Flusso di cassa netto:
$95.39M
1 W Prestazione:
-7.38%
1M Prestazione:
-13.56%
6M Prestazione:
-17.29%
1 anno Prestazione:
+1.22%
Intervallo 1D:
$32.12
$33.37
Intervallo di 1 settimana:
$32.12
$35.30
Portata 52W:
$29.06
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Nome
Omnicell Inc
Settore
Industria
Telefono
(877) 415-9990
Indirizzo
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, TXG, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
32.25 | 1.53B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
260.98 | 42.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.88 | 12.27B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
58.74 | 11.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
66.38 | 8.77B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
94.55 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-04 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2026-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-02 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Iniziato | Barclays | Underweight |
| 2023-11-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-11-03 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Reiterato | Wells Fargo | Underweight |
| 2023-08-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Downgrade | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Iniziato | BofA Securities | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2021-12-06 | Ripresa | Wells Fargo | Overweight |
| 2021-06-09 | Iniziato | JP Morgan | Neutral |
| 2021-05-24 | Iniziato | BTIG Research | Buy |
| 2021-02-02 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-12-03 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Iniziato | Stephens | Overweight |
| 2020-02-07 | Reiterato | Dougherty & Company | Buy |
| 2019-11-21 | Reiterato | Dougherty & Company | Buy |
| 2019-07-26 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-03-07 | Reiterato | Dougherty & Company | Buy |
| 2018-06-29 | Ripresa | The Benchmark Company | Buy |
| 2017-09-05 | Reiterato | The Benchmark Company | Buy |
| 2017-07-28 | Reiterato | Dougherty & Company | Buy |
| 2017-04-21 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Iniziato | Dougherty & Company | Buy |
| 2016-12-06 | Reiterato | The Benchmark Company | Buy |
| 2016-07-07 | Reiterato | FBR Capital | Outperform |
| 2016-03-21 | Reiterato | Topeka Capital Markets | Buy |
| 2016-01-07 | Iniziato | The Benchmark Company | Buy |
| 2015-11-16 | Reiterato | Topeka Capital Markets | Buy |
| 2015-10-30 | Reiterato | FBR Capital | Outperform |
| 2015-09-28 | Aggiornamento | Sidoti | Neutral → Buy |
| 2015-07-31 | Reiterato | Topeka Capital Markets | Buy |
Mostra tutto
Omnicell Inc Borsa (OMCL) Ultime notizie
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle By Investing.com - Investing.com Canada
Omnicell at Wells Fargo healthcare conference: betting on refresh cycle - Investing.com
Does Embedding TraceLink’s DSCSA Tools Into Omnicell Workflows Reframe Its Cloud and Recurring Revenue Story (OMCL)? - simplywall.st
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations - marketscreener.com
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations - The Malaysian Reserve
Craig-Hallum Maintains Omnicell(OMCL.US) With Buy Rating - Moomoo
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Omnicell Inc (OMCL) Stock Up 6.3% and Still Undervalued -- GF Sc - GuruFocus
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference - finance.yahoo.com
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
Omnicell Stock Price Forecast. Should You Buy OMCL? - StockInvest.us
Omnicell Inc. ($0.001 par value) (OMCL) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
KeyBanc reiterates Omnicell stock rating on large pipeline growth By Investing.com - Investing.com Canada
KeyBanc reiterates Omnicell stock rating on large pipeline growth - Investing.com
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Omnicell President Sells 6,753 Shares - The Motley Fool
Omnicell Market Sentiment - Benzinga España
Bank of America Corp DE Has $19.39 Million Position in Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) Quarterly Figures: The Bottom-Line Figure Beats Its Comparison; Stock Move: The Share Price Adds 1.28% in the Current UpdateFinancial Data - vinanet.vn
Zacks Research Has Bearish Estimate for Omnicell Q3 Earnings - MarketBeat
Rice Hall James & Associates LLC Invests $2.15 Million in Omnicell, Inc. $OMCL - MarketBeat
Omnicell VP and Chief Accounting Officer Submits Form 4 Detailing RSU Tax Withholding and ESPP Acquisition - Kalkine Media
Omnicell (OMCL) legal chief has 4,025 shares withheld for taxes - Stock Titan
Omnicell (NASDAQ: OMCL) exec holds 22,265.8924 shares after tax move - Stock Titan
Omnicell (NASDAQ: OMCL) CEO withholds stock to cover RSU taxes - Stock Titan
Research Analysts Set Expectations for Omnicell Q1 Earnings - MarketBeat
Omnicell (NASDAQ: OMCL) insider plans sale of 3,083 shares - Stock Titan
Omnicell, Inc. $OMCL Shares Acquired by Empowered Funds LLC - MarketBeat
Omnicell Raises 2026 EPS Outlook as Memory Costs Pressure Margins - TradingView
Q2 2026 Omnicell Inc Earnings Call Transcript - GuruFocus
Omnicell, Inc. (OMCL) Stock Forecasts - finance.yahoo.com
OMCL Falls 20.1% in a Month as Booking and Margin Risks Build - TradingView
Quantinno Capital Management LP Has $1.92 Million Position in Omnicell, Inc. $OMCL - MarketBeat
(OMCL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Omnicell, Inc. (OMCL) Stock Analysis: Strong Analyst Consensus with Over 55% Upside Potential - DirectorsTalk Interviews
Millennium reports 3.8% Omnicell (OMCL) stake in amended 13G filing - Stock Titan
Does Omnicell’s Profit Rebound And Higher 2026 Outlook Change The Bull Case For OMCL? - simplywall.st
First Trust Advisors LP Has $2.85 Million Stake in Omnicell, Inc. $OMCL - marketbeat.com
Royal Bank of Canada Sells 78,803 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OMNICELL, INC. 2026: Revenue $312.21M, EPS $0.52— 10-Q Summary - TradingView
Omnicell, Inc. (NASDAQ: OMCL) returns to profit with Q2 2026 growth - Stock Titan
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025. - marketscreener.com
Omnicell, Inc. (OMCL) - DirectorsTalk Interviews
Here's Why Omnicell (OMCL) is a Strong Value Stock - Eastern Progress
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability - Yahoo! Finance Canada
Weekly Recap: Omnicell, Inc. Q3/2026 revenue and analyst price target - TradingView
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $45 - Moomoo
Omnicell (OMCL) Stock May Be 42% Below Fair Value On Weak Guidance - finance.yahoo.com
Omnicell Inc Azioni (OMCL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.53%
2.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):